CRH Medical Corp (NYSEAMERICAN:CRHM) has been given a consensus rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $7.50.
Separately, Zacks Investment Research lowered shares of CRH Medical from a “buy” rating to a “hold” rating in a research report on Monday, January 15th.
Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. acquired a new position in shares of CRH Medical in the second quarter valued at about $150,000. Mawer Investment Management Ltd. grew its stake in shares of CRH Medical by 25.7% in the third quarter. Mawer Investment Management Ltd. now owns 5,963,519 shares of the company’s stock valued at $15,542,000 after acquiring an additional 1,221,028 shares in the last quarter. TD Asset Management Inc. grew its stake in shares of CRH Medical by 65.3% in the third quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock valued at $289,000 after acquiring an additional 43,851 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of CRH Medical by 69.1% in the third quarter. JPMorgan Chase & Co. now owns 410,100 shares of the company’s stock valued at $964,000 after acquiring an additional 167,600 shares in the last quarter. Finally, Stifel Financial Corp grew its stake in shares of CRH Medical by 7.7% in the third quarter. Stifel Financial Corp now owns 1,665,839 shares of the company’s stock valued at $4,332,000 after acquiring an additional 119,685 shares in the last quarter.
TRADEMARK VIOLATION WARNING: This report was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3302926/crh-medical-corp-crhm-receives-5-92-average-pt-from-analysts.html.
CRH Medical Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.